AI Moves Genetic Variant Interpretation Beyond Simple Pathogenicity Scores

Exome and genome sequencing have transformed the diagnosis of rare diseases, but they have also created a persistent bottleneck in clinical genomics: a steadily growing number of genetic variants that must be interpreted under uncertain and context-dependent evidence. A review published in Cell & Bioscience argues that this challenge is often misframed as a need for stronger variant-level classifiers. In clinical practice, the authors write, it reflects the broader need to assemble coherent evidence across molecular mechanism, gene-disease validity, penetrance, inheritance architecture, phenotype specificity, and longitudinal context.

The review, authored by Liu Liu, Minjia Lu, Duan Ma, Taosheng Huang, and Weidong Tian, centers its analysis on variants of uncertain significance, known as VUS. These are DNA changes whose biological plausibility and clinical proof remain incomplete, making them a particularly important clinical use case. Rather than being fixed labels, the authors describe VUS as dynamic evidence states—positions in an ongoing interpretive process where the available data are not yet sufficient to classify a variant as pathogenic or benign.

Artificial intelligence may reshape this interpretive process, the review suggests, by expanding the evidence that can be generated, prioritized, and organized. Recent advances in protein language models, long-sequence regulatory models, graph-learning approaches, phenotype-driven diagnostic systems, and multiplexed assays of variant effect are moving the field beyond isolated pathogenicity scoring. Instead of assigning definitive clinical labels, these methods generate complementary and probabilistic evidence across variant-effect prediction, penetrance estimation, gene prioritization, inheritance-architecture inference, functional evidence mining, and workflow-level decision support.

The authors organize AI-assisted variant interpretation around five areas: variant-effect prediction, penetrance estimation, gene prioritization, inheritance-architecture inference, and clinical decision support.

A recurring theme in the review is calibration. The point is not to replace expert judgment with machine output, but to ensure that probabilistic predictions from AI models can be translated into evidence categories that fit existing clinical classification standards.

The review also addresses emerging agentic systems, which may further support evidence retrieval and workflow coordination. However, the authors are explicit that the role of such systems in clinical variant classification remains preliminary. They require rigorous clinical validation before routine implementation, a caution that underscores the gap between promising computational tools and validated clinical practice.

Beyond validation, the review identifies several requirements for clinical use: evidence traceability, interoperability, and expert review.

The broader argument of the review is that variant interpretation should be understood as an evidence-centered clinical workflow rather than a scoring problem. The increasing number of variants requiring interpretation is not simply a computational scale issue; it is a structural feature of modern genomics in which molecular mechanism, gene-disease validity, penetrance, inheritance architecture, phenotype specificity, and longitudinal context must all be weighed together. AI, in this framing, is valuable not because it can produce a single definitive score, but because it can generate, prioritize, and organize the multiple strands of evidence that expert interpretation requires.

Published on 4 November 2026 as an open-access review, the article reflects a field in transition. The authors position VUS as the setting in which the need for organized, incomplete-evidence reasoning is most visible, and they frame the future of AI-assisted interpretation around calibration, validation, and expert oversight rather than around the promise of fully automated classification.

Subject of Research: AI-assisted interpretation of variants of uncertain significance in clinical genomics

Article Title: Artificial intelligence-assisted variant interpretation: from variant scoring to evidence-centered clinical workflows

Article References: Liu, L., Lu, M., Ma, D., Huang, T., & Tian, W. (2026). Artificial intelligence-assisted variant interpretation: from variant scoring to evidence-centered clinical workflows. Cell & Bioscience. https://doi.org/10.1186/s13578-026-01649-1

Image Credits: AI Generated

DOI: 10.1186/s13578-026-01649-1

Keywords: variant interpretation, variants of uncertain significance, clinical genomics, artificial intelligence, protein language models, ACMG/AMP framework, penetrance estimation, gene prioritization, clinical decision support, exome sequencing, genome sequencing, rare disease diagnostics